| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Leslie W. Kreis | 10%+ Owner | $8.17M | Dec 13, 2023 | ||
| Fletcher Aaron G.L. | 10%+ Owner | $8.17M | Dec 13, 2023 | ||
| William Tai-Wei Ho | PRESIDENT AND CEO, Director, 10%+ Owner | $2.4M | Sep 4, 2024 | ||
| Peter C. Brandt | Director | $351K | Jun 12, 2024 | ||
| Alan S. Roemer | Director | $151K | Jun 12, 2024 | ||
| Lawrence Lamb | EVP and CSO | $96.3K | Sep 4, 2024 | ||
| Corinne Epperly | Director | $77.9K | Jun 12, 2024 | ||
| Patrick McCall | Chief Financial Officer | $25.4K | Sep 4, 2024 | ||
| Kate Rochlin | Chief Operating Officer | $16.7K | Sep 4, 2024 | ||
| Trishna Goswami | Chief Medical Officer | $6.39K | Sep 4, 2024 | ||
| Jeremy R. Graff | Director | $4.32K | Jun 12, 2024 | ||
| Bios Clinical Opportunity Fund, LP | 10%+ Owner | Dec 13, 2023 | |||
| Travis Whitfill | Director | Jun 12, 2024 | |||
| Luba Greenwood | Director | Jun 12, 2024 | |||
| Melissa Beelen | VP, Clinical Operation | Jul 29, 2021 | |||
| Bios Equity Partners, LP | 10%+ Owner | Aug 13, 2021 | |||
| Emily Fairbairn | Director | Jun 12, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|